KOELIS

KOELIS is a France-based medical technology company specializing in MRI-ultrasound fusion imaging solutions for prostate cancer diagnosis, biopsy, and treatment. The company develops the KOELIS Trinity® System, an integrated mobile fusion imaging platform that combines 3D ultrasound with advanced imaging technology to provide millimetric accuracy in needle guidance during prostate interventions. Core proprietary technologies include OBT Fusion® (organ-based tracking that records biopsy core locations), 3D Ultrasound with automatic compensation for prostate and patient movement, and the 2nd Look option for comprehensive lesion evaluation and active surveillance. KOELIS also offers PROMAP-FT software for needle-based therapy guidance and specialized ultrasound probes. Operating in over 30 countries across North America, Europe, and Asia, the company has enabled precision prostate care for over 350,000 patients worldwide. KOELIS collaborates with leading academic medical centers and hospitals to advance personalized prostate cancer management and aims to democratize access to fusion-guided biopsy technology.